Literature DB >> 20965378

U.S. primary care physicians' lung cancer screening beliefs and recommendations.

Carrie N Klabunde1, Pamela M Marcus, Gerard A Silvestri, Paul K J Han, Thomas B Richards, Gigi Yuan, Stephen E Marcus, Sally W Vernon.   

Abstract

BACKGROUND: No high-quality study to date has shown that screening reduces lung cancer mortality, and expert groups do not recommend screening for asymptomatic individuals. Nevertheless, lung cancer screening tests are available in the U.S., and primary care physicians (PCPs) may have a role in recommending them to patients.
PURPOSE: This study describes U.S. PCPs' beliefs about and recommendations for lung cancer screening and examines characteristics of PCPs who recommend screening.
METHODS: A nationally representative survey of practicing PCPs was conducted in 2006-2007. Mailed questionnaires were used to assess PCPs' beliefs about lung cancer screening guidelines and the effectiveness of screening tests and to determine whether PCPs would recommend screening for asymptomatic patients. Data were analyzed in 2009.
RESULTS: Nine hundred sixty-two PCPs completed the survey (absolute response rate=70.6%; cooperation rate=76.8%). One quarter said that major guidelines support lung cancer screening. Two thirds said that low-radiation dose spiral computed tomography (LDCT) screening is very or somewhat effective in reducing lung cancer mortality in current smokers; LDCT was perceived as more effective than chest x-ray or sputum cytology. Responding to vignettes describing asymptomatic patients of varying smoking exposure, 67% of PCPs recommended lung cancer screening for at least one of the vignettes. Most PCPs recommending screening said they would use chest x-ray; up to 26% would use LDCT. In adjusted analyses, PCPs' beliefs and practice style were strongly associated with their lung cancer screening recommendations.
CONCLUSIONS: Many PCPs' lung cancer screening beliefs and recommendations are inconsistent with current evidence and guidelines. Provider education regarding the evidence base and guideline content of lung cancer screening is indicated. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20965378      PMCID: PMC3133954          DOI: 10.1016/j.amepre.2010.07.004

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  32 in total

1.  New approaches to lung cancer. Changing role for family physicians.

Authors:  D R Carlow
Journal:  Can Fam Physician       Date:  2001-03       Impact factor: 3.275

2.  Overview of the NCI Cooperative Early Lung Cancer Detection Program.

Authors:  N I Berlin
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

3.  Routine screening for lung cancer?: Maybe someday, but not yet.

Authors:  P S Frame
Journal:  JAMA       Date:  2000-10-18       Impact factor: 56.272

4.  Screening strategies for early detection of lung cancer: the time is now.

Authors:  T L Petty
Journal:  JAMA       Date:  2000-10-18       Impact factor: 56.272

5.  Direct-to-consumer marketing of high-technology screening tests.

Authors:  Thomas H Lee; Troyen A Brennan
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

Review 6.  Audit and feedback: effects on professional practice and health care outcomes.

Authors:  G Jamtvedt; J M Young; D T Kristoffersen; M A Thomson O'Brien; A D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2003

7.  Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality.

Authors:  J W Peabody; J Luck; P Glassman; T R Dresselhaus; M Lee
Journal:  JAMA       Date:  2000-04-05       Impact factor: 56.272

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

Review 9.  Patient self-referral for radiologic screening tests: clinical and ethical concerns.

Authors:  Joshua J Fenton; Richard A Deyo
Journal:  J Am Board Fam Pract       Date:  2003 Nov-Dec

10.  Enthusiasm for cancer screening in the United States.

Authors:  Lisa M Schwartz; Steven Woloshin; Floyd J Fowler; H Gilbert Welch
Journal:  JAMA       Date:  2004-01-07       Impact factor: 56.272

View more
  28 in total

Review 1.  Application of glycoproteomics for the discovery of biomarkers in lung cancer.

Authors:  Qing Kay Li; Edward Gabrielson; Hui Zhang
Journal:  Proteomics Clin Appl       Date:  2012-06       Impact factor: 3.494

2.  Attitudes about low-dose computed tomography screening for lung cancer: a survey of American Thoracic Society Clinicians.

Authors:  James Simmons; Michael K Gould; Steven Woloshin; Lisa M Schwartz; Renda Soylemez Wiener
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

3.  A qualitative analysis of lung cancer screening practices by primary care physicians.

Authors:  Susan Henderson; Amy DeGroff; Thomas B Richards; Julia Kish-Doto; Cindy Soloe; Christina Heminger; Elizabeth Rohan
Journal:  J Community Health       Date:  2011-12

4.  Underuse of Chest Radiography Versus Computed Tomography for Lung Cancer Screening.

Authors:  Samir Soneji; JaeWon Yang; Nichole T Tanner; Rui Dang; Gerard A Silvestri; William Black
Journal:  Am J Public Health       Date:  2017-08       Impact factor: 9.308

5.  Lung Cancer Screening Inconsistent With U.S. Preventive Services Task Force Recommendations.

Authors:  Thomas B Richards; V Paul Doria-Rose; Ashwini Soman; Carrie N Klabunde; Ralph S Caraballo; Simone C Gray; Keisha A Houston; Mary C White
Journal:  Am J Prev Med       Date:  2018-11-19       Impact factor: 5.043

6.  Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic Efficiency.

Authors:  David D Kim; Joshua T Cohen; John B Wong; Babak Mohit; A Mark Fendrick; David M Kent; Peter J Neumann
Journal:  Health Aff (Millwood)       Date:  2019-01       Impact factor: 6.301

7.  Lung cancer screening practices of primary care physicians: results from a national survey.

Authors:  Carrie N Klabunde; Pamela M Marcus; Paul K J Han; Thomas B Richards; Sally W Vernon; Gigi Yuan; Gerard A Silvestri
Journal:  Ann Fam Med       Date:  2012 Mar-Apr       Impact factor: 5.166

8.  Communication About the Probability of Cancer in Indeterminate Pulmonary Nodules.

Authors:  Amelia W Maiga; Stephen A Deppen; Pierre P Massion; Carol Callaway-Lane; Rhonda Pinkerman; Robert S Dittus; Eric S Lambright; Jonathan C Nesbitt; Eric L Grogan
Journal:  JAMA Surg       Date:  2018-04-01       Impact factor: 14.766

Review 9.  Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.

Authors:  Denise R Aberle; Fereidoun Abtin; Kathleen Brown
Journal:  J Clin Oncol       Date:  2013-02-11       Impact factor: 44.544

Review 10.  Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge.

Authors:  Qing Kay Li; Ed Gabrielson; Frederic Askin; Daniel W Chan; Hui Zhang
Journal:  Proteomics Clin Appl       Date:  2013-01       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.